USPTO serial 78528677
TYMPANOGRAFT
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- TIERNEY, MARGERY
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TYMPANOGRAFT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Camille M. Miller
Camille M. Miller COZEN O'CONNOR PC1900 MARKET STPHILADELPHIA, PA 19103UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific, laboratory and medical research; configurations, namely decellularized, square, round, with or without cells; biochemical catalysts for use in medical research; biological preparations for medical purposes, namely for use in the research of immunological, inflammatory and neurological disorders; catalysts for use in the manufacture of pharmaceuticals; chemical preparations, namely, chemical reagents for scientific purposes; enzyme preparations for industrial purposes; enzymes for industrial purposes; proteins for industrial and human consumption, namely animal proteins, genetic testing reagents for scientific laboratory use, namely, DNA probes; chemical preparations used to protect crops in the agricultural and horticultural field | ACTIVE | — |
| 005 | biological tissue intended for subsequent implantation namely, blood, stem cells, umbilical cords and placentas for medical and clinical use; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriological culture media for medical use; medicinal and biological preparations for pharmaceutical, clinical or medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system | ACTIVE | — |
| 042 | development of new technology for others in the field of genomics, biotechnology; discovery, development and commercialization of therapies designed to treat cancer and immunological diseases through regulation of cellular, genomic and proteomic targets; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods; agrochemical product development for others | ACTIVE | — |
| 044 | collection and preservation of human blood, umbilical cord blood, stem cells, umbilical cords and placentas; and providing medical and pharmaceutical information services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Celgene Corporation
- Other trademarks owned by Celgene Corporation
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TYMPANOGRAFT
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 2, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 2, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 7, 2008 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jun 27, 2008 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jun 27, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 25, 2008 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Dec 27, 2007 | EXT4 | SOU EXTENSION 4 FILED | — |
| Dec 27, 2007 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 31, 2007 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 12, 2007 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 12, 2007 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 24, 2007 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 28, 2006 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 28, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 2, 2006 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 2, 2006 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 2, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 31, 2006 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 8, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 19, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 21, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 16, 2005 | ALIE | ASSIGNED TO LIE | — |
| Sep 14, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 14, 2005 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 14, 2005 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 14, 2005 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 12, 2005 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 20, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 15, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jul 12, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 12, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2005 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 20, 2004 | NWAP | NEW APPLICATION ENTERED | — |